Skip to main content

Advertisement

Log in

Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Januschowski K, Feltgen N, Pielen A et al (2016) Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. doi:10.1007/s00417-016-3471-2

    Google Scholar 

  2. Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS (2006) Normal macular thickness measurements in healthy eyes using stratus optical coherence tomography. Arch Ophthalmol 124:193–198

    Article  PubMed  PubMed Central  Google Scholar 

  3. Gover S, Murthy RK, Brar VS, Chalam KV (2009) Normative data formacular thickness by high-definition spectral-domain optical coherence tomography (spectralis). Am J Ophthalmol 148:266–271

    Article  Google Scholar 

  4. Freund KB, Korobelnik JF, Deveny R et al (2015) Treat-and extend regimens with anti-VEGF agents in retinal diseases. Retina 35:1489–1506

    Article  CAS  PubMed  Google Scholar 

  5. Epstein DL, Algvere PV, von Wendt G, Seregard S, Kvanta A (2012) Benefict of bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study. Ophthalmology 119:2587–2591

    Article  PubMed  Google Scholar 

  6. Călugăru D, Călugăru M (2015) Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study. J Ocul Pharmacol Ther 31:78–86

    Article  PubMed  Google Scholar 

  7. Călugăru D, Călugăru M (2016) Central retinal vein occlusion: modifying current treatment protocols. Eye (Lond) 30:1395–1396

    Article  Google Scholar 

  8. Călugăru D, Călugăru M (2016) Intravitreal aflibercept for macula oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab and ranibizumab. Eye (Lond) 30:766

    Google Scholar 

  9. Călugăru D, Călugăru M (2016) Retinal vein occlusion, from basics to the latest treatment. Retina 36:e112–e113

    Article  PubMed  Google Scholar 

  10. Călugăru D, Călugăru M (2015) Therapies for macular edema associated with central retinal vein occlusions. Ophthalmology 122:e65–e66

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mihai Călugăru.

Ethics declarations

Disclosure

All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. No financial disclosures. Both authors (D.C. and M.C.) were involved in design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript.

The authors have full control of the primary data and they agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review their data if requested.

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Călugăru, D., Călugăru, M. Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 255, 1043–1044 (2017). https://doi.org/10.1007/s00417-017-3617-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-017-3617-x

Keywords

Navigation